Check out the newest from our own Kristin Konnyu, "Identifying behaviour change techniques within precision health interventions that use continuous glucose monitoring: a secondary analysis of a scoping review". More info and link to the paper are here: www.linkedin.com/feed/update/...

Are you someone living with or beyond cancer? Researchers at the University of Aberdeen are inviting you to participate in a questionnaire about taking care of your health. More info and questionnaire here: iahs.qualtrics.com/jfe/form/SV_...

Thrilled to welcome @nhslothian.bsky.social & @Jubilee Hospital to the @nihr.bsky.social funded EVEREST trial team! Exciting times ahead as we explore new frontiers in takotsubo research ⛰️#Research #EVERESTTrial #Takotsubo #CHaRTtrials @Dana Dawson

Happy birthday #ELIPSE! 🥳🎂 Heer Lab, Vishwanath Hanchanale, Krishna Narahari @benchallacombe.bsky.social @jimcatto.bsky.social @bursturology.bsky.social

It’s the Edinburgh Clinical Trial Management Course next month. Great educational opportunity for those involved or interested in trial management. Supported by our own Shaun Treweek and CHaRT trial managers Kirsteen, Lynda, Suzanne and Seonaidh. clinical-research-facility.ed.ac.uk/edinburgh-cl...

We’re delighted to welcome @WWLNHS to the @NIHRresearch funded EVEREST Trial team! 🏔️Excited to work together on this important study. #Research #EVERESTTrial #Takotsubo #CHaRTtrials

🎉🎉Pleased to announce new publication in Translational Behavioral Medicine, our Kristin Konnyu is a co-author : Using the behavior change technique ontology to characterize the content of implementation strategies: A secondary analysis of 151 trials doi.org/10.1093/tbm/...

🏔️We’ve reached Base Camp! Recruitment for the @nihr.bsky.social funded EVEREST Trial is officially a go 🚦 1st Green Light issued. Here’s to scaling new heights in Takotsubo research. #EVERESTTrial #Takotsubo #CHaRTtrials @nhsgrampian.bsky.social @dana_dawson16

(1/2) Our Kristin Konnyu is part of one of the strand of the £11.5M @ukri.org funded Transforming Global Evidence project- Methods Work Package. The work will focus on methods development to create AI enhanced 'living #evidencesyntheses ' to inform policymakers the best evidence, more efficient.

From 1st Jan 2026, the journal Trials will mandate reporting of (at least) six participant characteristics for both protocols and reports of trial results. Read more in the editorial: trialsjournal.biomedcentral.com/articles/10.... @ukcrc-ctu.org.uk @ecrin.bsky.social

Great news from Trial Forge, @streweek.bsky.social and team: Journal Trials mandating the use of a tool called PRO EDI to address the gap in reporting and interpretation of equity information. More info here👉 abdn.io/1H4

One of the key things to address when undertaking a feasibility study ahead of a trial is the acceptability of different aspects of the proposed trial (intervention, trial processes, proposed outcomes etc) to all relevant parties 1/7 #MethodologyMonday #125

📣 Our @streweek.bsky.social is lead author on an editorial in #Trials outlining a new mandate in the journal - mandating the reporting of six key participant characteristics in any protocol/trial report submitted to Trials on or after 1st Jan 2026. 1/2 trialsjournal.biomedcentral.com/articles/10....

Great public engagement work this weekend from our amazing team 🤩

We are co-authors on 2 new papers in @bonejointjournal.bsky.social - one on the potential of Bayesian trials in T&O and a Bayesian reanalysis of the WHiTE8 trial. And … our own Jemma Hudson is the featured author 😊 @docfarrow.bsky.social @marionkcampbell.bsky.social Links to papers below 👇

Kirsteen Goodman, the trial manager for DIETRICH (funded by @ProstateUK) is riding in the #SirChrisHoy @TourDe4 on 7 September. bit.ly/3Vqbwqq

@Krish_Narahari @jonathananing @Heer_Lab @vishhanchanale @benchallacombe @BURSTurology

There has been a lot of debate recently about the promise of real world data - the routine (observational) data collected on patients eg  treatments received, clinical outcomes etc – for estimating treatment effects. But can they deliver? 1/9 #MethodologyMonday #123

Have you registered for this year's #Edinburgh #ClinicalTrial Management Course? A 2-day course for those involved and new to #clinicalresearch | 6 & 7 Nov 2025 | Book here edin.ac/3RGb0mB #ECTMC25 @streweek.bsky.social reweek.bsky.social‬ @bleedingstroke.bsky.social @ace-aberdeen.bsky.social

Two of the key findings are: ➡️ The considerable emotional labour involved in patient feedback ➡️ Direct changes from individual feedback stories were limited but change can occur in other ways @louiselocock.bsky.social @marionkcampbell.bsky.social @ace-aberdeen.bsky.social

A few familiar faces from @ace-aberdeen.bsky.social & #CHaRT appearing in this @uniofaberdeen.bsky.social montage from #tallshipraces2025 where we celebrated #ClinicalTrials & #JamesLind and recruited over 700 members of the public to our #LimeorBrineTrial www.instagram.com/reel/DMrrrfJ...

1/2 Snapshots of ACE/CHaRT at the magnificent at Tall Ships 2025⚓. Visitors have fun with our “Lime or Brine” trial! bit.ly/4lKTD1o

📣 Another paper from the “Game Of Stones” randomised trial has been published! This work in the journal Obesity delves into the secondary analysis of the trial for men with obesity: examining moderator effects and exploratory outcomes. See onlinelibrary.wiley.com/doi/10.1002/...

Congratulations to Dr Shazia Yousuf as she celebrates her graduation ceremony today at the University of Aberdeen! A proud moment for all of us at the Aberdeen Centre for Evaluation. Wishing you every success, Dr Yousuf👩‍🎓 #ClassOf2025 #GraduationDay

Research participants needed📢 Do you have experience recruiting patients into clinical trials in the UK and Ireland? Do you think recruitment targets are motivating? Are they communicated well? Then we would love to hear from you as a participant in our focus group study.

We contributed to the Game of Stones study that was published in JAMA last year jamanetwork.com/journals/jam.... Two of the participants have written about their experiences of taking part in research. It can be life-changing!

We marked #VolunteersWeek2025 with a special ACE event on 3 June to honour our fantastic PPI group 🎉 Delighted to be joined by the Lord Provost of Aberdeen, Prof David Blackbourn & Prof Peter Edwards. Huge thanks to all our research volunteers, study participants and PPI partners! 💙

ACE's Professor Miriam Brazzelli will be one of the presenters at the UK NSC online seminar on breast screening and breast density, 2-3.30pm 9 June. For more information and to register visit: nationalscreening.blog.gov.uk/2025/05/02/s...

Congrats to the fantastic team at Southmead, for randomising two more ptts this morning!! You are in the top two sites for randomisations! Amazing work from an outstanding team!! #Elipse

We are delighted to share that SPIROMAC has recruited to target with 550 families taking part across the UK. Huge thank you to everyone involved, especially our participants. What an amazing achievement!

🥳🎉 @nhsggc.bsky.social @jonathananing.bsky.social @benchallacombe.bsky.social Heer Lab, Vishwanath Hanchanale, Krishna Narahari

Congratulations to Mr Dudderidge and his team at Southampton for randomising their first participant one day after receiving the Green Light form. What an amazing team! #ELIPSE @uhsft.bsky.social @jonathananing.bsky.social @benchallacombe.bsky.social

Clinical Trial Manager opportunity working with us and colleagues @blizardinstitute.bsky.social @qmulfmd.bsky.social in a pan-London trauma RCT, studying the impact of AI-powered decision-support bit.ly/4kzZ0iD. Apply at www.jobs.ac.uk/job/DNE613/c...

A huge thank you to all our collaborators for coming along to our #ELIPSE meeting @benchallacombe.bsky.social @veerukasi.bsky.social

If you want more trials methods research post #SCT2025 please do come to #ICTMC2026 in Birmingham UK 14-17 September. More here ictmc.org

#ClinicalTrialsDay is the time to consider how to ensure the environmental sustainability of clinical trials. Read our @frankskyou.bsky.social write about why and how greener trials serve the purpose of benefiting the coming generations on SpringerNature blog: bit.ly/4moCL11

Congratulations to all the PIs and their teams for helping us in getting ELIPSE set up in 25 sites and meeting our site target” #Elipse 🎉🎉

Our ELIPSE trial is now on CRUK as one of the trials patients can participate in! See: www.cancerresearchuk.org/about-cancer...

Great to see the updated CONSORT Statement published - really important for the field of clinical trials … and also great to see our @marionkcampbell.bsky.social is a co-author of this important development

The PANDOS study has recruited over 8000 ppts since September 2023 across the UK and Europe. Congratulations to all the teams that have been part of this amazing achievement.🎉🎉

On this #InternationalNursesDay a huge thank you to all the research nurses who directly support all our trials and studies & make them happen 🙏

Every clinical trial is a puzzle. When participants drop out we lose pieces, and the picture becomes unclear 🧩. Help to be part of the solution! 🗓️ Closing date: 16-May-2025. 📌 bit.ly/3RM0H0h

For interest, please contact our researcher at abdn.ac.uk for details.

📢Research participants needed📢 Do you work in the field of clinical trials? We would love to hear from you as a participant in our focus group study or one-to-one interview to understand what enables and challenges us to make clinical trials greener.🌍

<Research participants needed> Do you work in clinical trials? Please take part in our survey that explores the practices of sharing recruitment and/or retention rates with recruiting sites to improve recruitment and/or retention behaviours: bit.ly/4jySw3C

Clinical trials are nothing without their participants and it is key that the results of trials are shared with them. But this is still not routinely done. 1/7 #MethodologyMonday #115

What ticks to serve as healthcare staff in rural and remote areas in the UK? Let's hear what people working in the field are saying in this paper.

🆕Paper📢 In their follow-up study in ‘Tolerating bad health research’, Shaun Treweek and colleagues conducted risk of bias assessment of 140 UK, Irish and Canadian trials. Despite the bad trials (55%), trials judged to be good increased from 9% to 16%. trialsjournal.biomedcentral.com/articles/10....

Interested in audit and feeback strategies and how they may improve healthcare practice? Then check out the updated Cochrane review on the topic, co-authored by our own Kristin Konnyu: Audit and feedback: effects on professional practice - Ivers, N - 2025 www.cochranelibrary.com/cdsr/doi/10....

Congratulations to our own Emma Berry for being shortlisted for a Principal's Excellence Award in the category "Public Engagement with Research - Early Career Award"! Fingers crossed come awards night 🤞 www.abdn.ac.uk/students/eve...